Hope, backed by science
Research & breakthroughs
Cancer science is advancing faster than ever. Here's what's genuinely changing outcomes, how the research gets funded, and how you can be part of it.
Breakthroughs changing what a diagnosis means
Cancer research is moving faster than at any point in history. These are the advances your oncologist is genuinely excited about.
Immunotherapy & checkpoint inhibitors
Drugs that unmask cancer cells so the immune system can destroy them have transformed melanoma, lung cancer, and more — producing durable remissions in some patients with advanced disease, something almost unheard of two decades ago.
CAR T-cell therapy
A patient's own immune T-cells are collected, engineered in a lab to recognize their cancer, and returned as a living drug. Approved for several blood cancers, with response rates that stunned even researchers.
Precision oncology
Sequencing a tumor's DNA to match patients with drugs targeting their cancer's exact mutations. Increasingly, treatment is chosen by a tumor's biology rather than just its location in the body.
Liquid biopsies & early detection
Blood tests that detect fragments of tumor DNA are being developed to catch cancers earlier, monitor treatment response, and spot recurrence months before scans can.
Cancer vaccines
Beyond preventive vaccines like HPV (which is already preventing cervical cancer worldwide), personalized mRNA vaccines that train the immune system against a patient's specific tumor are in advanced clinical trials.
Antibody-drug conjugates
"Smart missiles" that pair a targeting antibody with a potent chemotherapy payload, delivering the drug directly to cancer cells while largely sparing healthy tissue.
How cancer research gets funded
Behind every new treatment is a funding chain that typically spans decades:
- Government funding — in the U.S., the National Cancer Institute (part of the NIH) is the world's largest funder of cancer research, supporting basic science, clinical trials, and cancer centers nationwide.
- Nonprofit and philanthropic funding — organizations like the American Cancer Society, Stand Up To Cancer, the Leukemia & Lymphoma Society, and disease-specific foundations fund early-stage and high-risk research that might not otherwise happen.
- Industry funding — pharmaceutical and biotech companies fund the large, late-stage clinical trials required to bring a drug to approval.
- You — charitable donations, community fundraisers, and, most powerfully, clinical trial participation. Every approved cancer drug exists because patients volunteered for trials.
Should you consider a clinical trial?
Clinical trials aren't a last resort — they're often how patients access tomorrow's treatment today, with close monitoring by expert teams. Participants always receive at least the current standard of care. Good questions to ask your oncologist: Is there a trial that fits my cancer and stage? What would it involve? What are the possible benefits and risks for me specifically?
You can search open trials yourself at the NCI's clinical trial finder or ClinicalTrials.gov, then bring what you find to your care team.